Concepedia

Publication | Open Access

The PI3K/mTOR dual inhibitor P7170 demonstrates potent activity against endocrine-sensitive and endocrine-resistant ER+ breast cancer

DOIFull Paper Access

15

Citations

38

References

2014

Year

Jennifer R. Bean, Sarah R. Hosford, Lynn Symonds, Philip Owens, Lloye M. Dillon, Wei Yang, Kevin Shee, Gary N. Schwartz, Jonathan D. Marotti, Kristen E. Muller,
Breast Cancer Research and Treatment

References

YearCitations

Page 1